Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy
Joseph M. Herman(Northwell Health), Howard M. Sandler(Cedars-Sinai Medical Center), Kent A. Griffith(University of Michigan), James E. Montie(University of Michigan), Molly A. Sullivan(University of Michigan), Peggy S. Esper(University of Michigan), James A. Hayman(University of Michigan), David C. Smith(University of Michigan), Elizabeth C. Kent(National Oceanography Centre)
Cited by 37
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Global analyses of sea surface temperature, sea ice, and night marine air temperature since the late nineteenth century
|Journal of Geophysical Research Atmospheres|2003|11.4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k